Purchase Order 36C26126P0330
- Not listed
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a leading provider of advanced cardiovascular medical devices, has been awarded a firm fixed-price purchase order by Veterans Integrated Service Network (VISN) 23 for transcatheter aortic valve replacement (TAVR) equipment. The contract, awarded on September 19, 2025, carries a ceiling value of $34,000 and an ultimate completion date of September 22, 2025, with performance to be fulfilled in Minneapolis, Minnesota....
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and self-certified small disadvantaged business, has been awarded a firm fixed-price purchase order valued at $34,000 by Veterans Integrated Service Network (VISN) 23 for transcatheter aortic valve replacement (TAVR) medical devices. The contract was awarded on November 10, 2025, with an ultimate completion date of November 12, 2025, and will be performed in Minneapolis, Minnesota. This award represents a direct...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a global leader in cardiovascular medical devices, was awarded a firm fixed-price purchase order on December 8, 2025, by Veterans Integrated Service Network (VISN) 23 for TAVR (transcatheter aortic valve replacement) equipment and related products. The contract, with a ceiling value of $34,000, has an ultimate completion date of December 10, 2025, and will be performed in Minneapolis, Minnesota. No set-aside...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation, has been awarded a firm fixed-price purchase order valued at $32,500 by the U.S. Department of Veterans Affairs through Veterans Integrated Service Network 21 for the restock of transcatheter aortic valve replacement (TAVR) surgical implants and related prosthetics. The contract, which carries no set-aside designation, is scheduled for completion by March 14, 2026, with the place of performance located in San...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a leader in cardiovascular medical devices, has been awarded a $34,000 firm fixed-price purchase order by the Department of Veterans Affairs' Veterans Integrated Service Network 23 (VISN 23). The contract, designated as a TAVR (transcatheter aortic valve replacement) award, does not utilize a set-aside designation and was awarded on July 23, 2025, with an ultimate completion date of the same day. The place of...
- Edwards Lifesciences LLC, a leading cardiovascular medical device manufacturer and subsidiary of Edwards Lifesciences Corporation, has been awarded a firm fixed-price purchase order valued at $34,000 by Veterans Integrated Service Network (VISN) 22 for prosthetic emergency heart valves. The contract, awarded on November 6, 2025, with performance in Irvine, California, carries a completion date of December 31, 2025. This award represents a non-set-aside procurement through the Department of...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a recognized leader in cardiovascular medical devices, was awarded a firm fixed-price purchase order contract by Veterans Integrated Service Network 20 on November 12, 2025, for prosthetics related to transcatheter aortic valve replacement (TAVR) technology. The contract, valued at $136,000 with an ultimate completion date of November 11, 2026, will be performed in Irvine, California. No set-aside designation was used...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a leader in cardiovascular medical devices, was awarded a $34,000 firm fixed-price purchase order by Veterans Integrated Service Network (VISN) 23 on December 12, 2025, with an ultimate completion date of December 15, 2025. The contract, designated as a TAVR (Transcatheter Aortic Valve Replacement) procurement, will be performed in Minneapolis, Minnesota. This award represents no set-aside designation and reflects the...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a leading provider of advanced cardiovascular medical devices, has been awarded a $34,000 firm fixed-price purchase order by Veterans Integrated Service Network (VISN) 23 for specialized transcatheter aortic valve replacement (TAVR) products. The contract, awarded on June 9, 2025, with a completion date of June 11, 2025, is for delivery to Minneapolis, Minnesota. No set-aside designation was applied to this award, and...
- Edwards Lifesciences LLC has been awarded a $34,000 firm fixed-price purchase order by Veterans Integrated Service Network 21 (VISN 21) for prosthetics related to transcatheter aortic valve replacement (TAVR) procedures. The contract, awarded on December 8, 2025, has an ultimate completion date of January 8, 2026, and will be performed in Palo Alto, California. This purchase order represents a direct procurement of specialized cardiovascular medical devices from Edwards Lifesciences LLC, the...
Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a global leader in cardiovascular medical devices, has been awarded a $204,000 firm fixed-price purchase order by Veterans Integrated Service Network (VISN) 21 for prosthetics related to transcatheter aortic valve replacement (TAVR) procedures. The contract, awarded on January 13, 2026, with an ultimate completion date of February 13, 2026, will be performed in Palo Alto, California. This award represents a continuation of Edwards Lifesciences LLC's established relationship with the Department of Veterans Affairs, which relies on the company as the sole manufacturer and supplier of specialized transcatheter heart valve technologies to support veteran healthcare. The contract contains no set-aside designation and reflects Edwards Lifesciences LLC's critical role within the VA system, where the company supplies advanced cardiovascular devices across multiple VISNs through both individual purchase orders and larger indefinite delivery contracts. The company's portfolio of VA contracts includes specialized products such as SAPIEN 3 transcatheter heart valves with RESILIA tissue technology and various annuloplasty systems, all of which support complex cardiac surgical procedures delivered to veteran populations. As a self-certified small disadvantaged business, Edwards Lifesciences LLC maintains a strategic position in providing essential, short shelf-life medical technologies that directly impact veteran patient outcomes.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
6515--PROS-122225-1590716-PA-EDWARDS (VA-26-00034803) | 36C26126AP20356701 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 | Award Notice 1/1 | 1/13/26, 2:12 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $204.0k | 1/13/26 |